| YHP2511 + YHP2511A | Yuhan | Phase 1 | Recruiting | |
| ASP8232 + Placebo | Astellas Pharma | Phase 1/2 | Completed | |
| CT-P43 + EU-approved Stelara + US-licensed Stelara | Celltrion | Phase 1 | Completed | |
| YHP2406 + YHR2501 | Yuhan | Phase 1 | Completed | |
| Bempedoic acid + Ezetimibe + Atorvastatin | Daiichi Sankyo | Phase 1 | Completed | |
| Quizartinib dihydrochloride + 14C-Quizartinib solution for infusion | Daiichi Sankyo | Phase 1 | Completed | |
| Bempedoic acid + Ezetimibe + Rosuvastatin | Daiichi Sankyo | Phase 1 | Completed | |
| Quizartinib + Rufinamide | Daiichi Sankyo | Phase 1 | Completed | |
| Quizartinib | Daiichi Sankyo | Phase 1 | Completed | |
| Efavirenz + Quizartinib | Daiichi Sankyo | Phase 1 | Completed | |
| Dabigatran Etexilate Mesylate + Quizartinib | Daiichi Sankyo | Phase 1 | Completed | |
| Bempedoic acid + Ezetimibe + Rosuvastatin | Daiichi Sankyo | Phase 1 | Completed | |
| Bempedoic acid + Ezetimibe + Atorvastatin | Daiichi Sankyo | Phase 1 | Completed | |
| MDV3100 | Astellas Pharma | Phase 1 | Completed | |
| MDV3100 + Gemfibrozil + Itraconazole | Astellas Pharma | Phase 1 | Completed | |
| ASP015K + verapamil | Astellas Pharma | Phase 1 | Completed | |
| ESN364 + Placebo | Astellas Pharma | Phase 1 | Completed | |
| Isavuconazole + Prednisone | Astellas Pharma | Phase 1 | Completed | |
| ASP015K | Astellas Pharma | Phase 1 | Completed | |
| ASP1941 + Glimepiride | Astellas Pharma | Phase 1 | Completed | |
| Mirabegron + Solifenacin + Digoxin | Astellas Pharma | Phase 1 | Completed | |
| ASP015K + Placebo | Astellas Pharma | Phase 1 | Completed | |
| ASP6294 Intravenous + ASP6294 Subcutaneous + Placebo Intravenous + Placebo Subcutaneous | Astellas Pharma | Phase 1 | Completed | |
| peficitinib + Metformin | Astellas Pharma | Phase 1 | Completed | |
| Pilocarpine + Placebo | Astellas Pharma | Phase 1 | Completed | |
| Placebo + mirabegron + moxifloxacin | Astellas Pharma | Phase 1 | Completed | |
| ASP8302 + Placebo | Astellas Pharma | Phase 1 | Completed | |
| ASP1707 + Placebo | Astellas Pharma | Phase 1 | Completed | |
| ASP015K + Mycophenolate Mofetil | Astellas Pharma | Phase 1 | Completed | |
| ASP2408 + Placebo | Astellas Pharma | Phase 1 | Completed | |
| ASP5354 + Placebo | Astellas Pharma | Phase 1 | Completed | |
| Mirabegron + Solifenacin succinate + Tamsulosin HCl + Placebo | Astellas Pharma | Phase 1 | Completed | |
| ASP1517 + Lanthanum carbonate hydrate | Astellas Pharma | Phase 1 | Completed | |
| ASP015K + Placebo | Astellas Pharma | Phase 1 | Completed | |
| ASP1517 | Astellas Pharma | Phase 1 | Completed | |
| ASP2151 + Placebo | Astellas Pharma | Phase 1 | Completed | |
| isavuconazole + sirolimus | Astellas Pharma | Phase 1 | Completed | |
| ASP3652 | Astellas Pharma | Phase 1 | Completed | |
| YM178 OCAS + Ketoconazole | Astellas Pharma | Phase 1 | Completed | |
| ASP1941 | Astellas Pharma | Phase 1 | Completed | |
| Placebo + ASP1941 + Moxifloxacin | Astellas Pharma | Phase 1 | Completed | |
| Fezolinetant | Astellas Pharma | Phase 1 | Completed | |
| MDV3100 | Astellas Pharma | Phase 1 | Completed | |
| Isavuconazonium sulfate IV + Isavuconazonium sulfate capsules | Astellas Pharma | Phase 1 | Completed | |
| ASP3652 + Placebo | Astellas Pharma | Phase 1 | Completed | |
| ASP015K + Rosuvastatin | Astellas Pharma | Phase 1 | Completed | |
| isavuconazole + Mycophenolate mofetil | Astellas Pharma | Phase 1 | Completed | |
| Ipragliflozin + Furosemide | Astellas Pharma | Phase 1 | Completed | |
| YM178 (mirabegron) | Astellas Pharma | Phase 1 | Completed | |
| GSK1349572 250 mg + Placebo Suspension + Moxifloxacin 400 mg | Shionogi | Phase 1 | Completed | |
| GSK1349572 | Shionogi | Phase 1 | Completed | |
| Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg + Dolutegravir 50 mg + abacavir 600 mg/lamivudine 300 mg | Shionogi | Phase 1 | Completed | |
| GSK1349572 + GSK1349572 | Shionogi | Phase 1 | Completed | |
| GSK1349572 | Shionogi | Phase 1 | Completed | |
| Torrent's Fluoxetine Tablets + Warner Chilcott LLC's Sarafem Tablet | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Olmesartan Medoxomil Tablets 40 mg + Daiichi Sankyo Inc's Benicar Tablets 40 mg | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Olmesartan Medoxomil Tablets 40 mg + Daiichi Sankyo Inc's Benicar Tablets 40 mg | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets + Tribenzor Tablets of Daichi Sankyo Inc, USA | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Nexium 40 mg DR Capsules of AstraZeneca LP, USA + Torrent's Esomeprazole Magnesium DR Capsules 40 mg | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Nebivolol Tablets + Forest Pharmaceuticals Inc's Bystolic Tablets | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Rosuvastatin Calcium Tablets 40 mg + Crestor 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Rosuvastatin Calcium Tablets 40 mg + Crestor 40 mg Tablets of AstraZeneca LP, USA | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Nebivolol Tablets + Forest Pharmaceuticals Inc.'s Bystolic Tablets | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Fluoxetine Tablets + Warner Chilcott LLC Sarafem Tablets | Torrent Pharmaceuticals | Phase 1 | Completed | |
| Torrent's Olmesartaan medoxomil, Amlodipine and Hydrochlorothiazide Tablets + Tribenzor of Daichi Sankyo Inc. USA | Torrent Pharmaceuticals | Phase 1 | Completed | |
| APD356 10 mg + APD356 XR-20 mg + APD356 10 mg matching Placebo + APD356 XR-20 mg matching Placebo + APD356 20 mg + APD356 20 mg matching Placebo + APD356 XR-20 mg (orange tablet) + APD356 XR-20mg (orange tablet, fed state) | Eisai | Phase 1 | Completed | |
| Perampanel | Eisai | Phase 1 | Completed | |
| E5501 + E5501 + E5501 + E5501 | Eisai | Phase 1 | Completed | |
| LEM5 + LEM10 + ZOL + PBO | Eisai | Phase 1 | Completed | |
| E2006 | Eisai | Phase 1 | Completed | |
| E2007 | Eisai | Phase 1 | Completed | |
| E2307 + E2307 Matching Placebo | Eisai | Phase 1 | Completed | |
| Lemborexant + Alcohol + Placebo | Eisai | Phase 1 | Completed | |
| lemborexant + Loestrin + famotidine + fluconazole | Eisai | Phase 1 | Completed | |
| E0302 SR1 + E0302 SR3 + E0302 SR2 + E0302 IR | Eisai | Phase 1 | Completed | |
| E7050 | Eisai | Phase 1 | Completed | |
| E5555 100 mg and diltiazem + E5555 300 mg and diltiazem | Eisai | Phase 1 | Completed | |
| E5501 + E5501 + E5501 | Eisai | Phase 1 | Completed | |
| E2027 + E2027 matched placebo | Eisai | Phase 1 | Completed | |
| E2022 | Eisai | Phase 1 | Completed | |
| rifampin 600 mg + itraconazole 200 mg + midazolam 2 mg with bupropion 75 mg + E2006 | Eisai | Phase 1 | Completed | |
| E2609 + Placebo | Eisai | Phase 1 | Completed | |
| Perampanel | Eisai | Phase 1 | Completed | |
| E2027 + Diltiazem ER | Eisai | Phase 1 | Completed | |
| Placebo + E2609 + Moxifloxacin | Eisai | Phase 1 | Completed | |
| E2609 + itraconazole + rifampin + digoxin + donepezil | Eisai | Phase 1 | Completed | |
| E5555 + E5555 | Eisai | Phase 1 | Completed | |
| CT-P47 + EU-approved RoActemra, | Celltrion | Phase 1 | UNKNOWN | |
| CT-P47 + CT-P47 | Celltrion | Phase 1 | UNKNOWN | |
| Moxifloxacin + Placebo + Lanifibranor + Placebo | Inventiva | Phase 1 | Completed | |
| ASP2205 + Placebo | Astellas Pharma | Phase 1 | Terminated | |